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Autoimmune	   diseases	   may	   present	   as	   paraneoplastic	   syndrome.	   This	   is	   especially	   recognized	   in	   the	   case	   of	  
polymyositis/dermatomyositis,	   but	   is	   less	   common	   in	   polymyalgia	   rheumatica.	   The	   authors	   describe	   the	   case	   of	   a	  
73-­‐year-­‐old	   man	   who	   presented	   with	   pain	   and	   stiffness	   of	   the	   scapular	   and	   pelvic	   girdles	   associated	   with	   asthenia	  
lasting	   for	  a	   few	  weeks.	  The	  presence	  of	   therapeutic	   resistance	  and	  other	  atypical	   features	  directed	  the	   investigation	  
towards	   the	   search	   of	   an	   occult	  malignancy.	   Patient	   evaluation	   revealed	   a	   pancreatic	   neuroendocrine	   tumour.	   After	  
surgical	  treatment	  of	  the	  underlying	  neoplasia,	  the	  patient	  recovered	  fully	  with	  resolution	  of	  the	  rheumatic	  disease.	   	  
	  
	   	  






Paraneoplastic	   syndrome	   (PNS)	   is	   defined	   by	   signs	   or	   symptoms	   related	   to	   a	   tumour	   without	   a	   direct	   anatomical	  
relationship	  with	  it,	  not	  explained	  by	  metastatic	  disease	  [1].	  
Polymyalgia	  rheumatica	  (PMR)	  is	  an	  inflammatory	  condition	  belonging	  to	  the	  connective	  tissue	  diseases,	  which	  occurs	  
quite	  frequently	  in	  the	  elderly.	  In	  case	  of	  atypical	  manifestations	  or	  the	  absence	  of	  an	  adequate	  response	  to	  treatment,	  
it	   should	   trigger	   an	  extensive	   aetiological	   investigation.	   There	  have	  been	  a	   few	   cases	   that	   report	   an	  association	  with	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Pancreatic	  neuroendocrine	   tumours	   represent	   a	   small	   percentage	  of	  pancreatic	  neoplasms	   (1%–2%)	   [2].	  Diagnosis	  of	  
neuroendocrine	  tumours	  is	  very	  difficult,	  especially	  if	  the	  tumours	  are	  small	  and	  non-­‐functional.	  
The	  authors	  report	  a	  rare	  case	  of	  PMR	  as	  a	  paraneoplastic	  manifestation	  of	  a	  pancreatic	  neuroendocrine	  neoplasm.	  
	  
Case	  report	   	  
A	  73-­‐year-­‐old	  man	  was	  admitted	  to	  the	  emergency	  department	  (ED)	  complaining	  of	  symmetrical	  aching	  and	  stiffness	  of	  
the	  scapular	  and	  pelvic	  girdles,	  which	  had	  begun	  a	  few	  weeks	  earlier.	  The	  patient	  also	  described	  asthenia,	  pain	  of	  the	  
wrists	  and	  morning	  stiffness.	  There	  were	  no	  other	  associated	  complaints.	  
He	  had	  already	  been	  medicated	  with	  diclofenac	  and	  etoricoxib	  without	  improvement.	  
The	  patient	  had	  no	  clinical	  records	  and	  was	  not	  taking	  any	  chronic	  medication.	   	  
The	  physical	  examination	  showed	  bilateral	  tenderness	  of	  the	  muscles	  of	  the	  arms,	  shoulders	  and	  hips	  in	  the	  absence	  of	  
peripheral	  arthritis.	  He	  was	  unable	  to	  stand	  up	  from	  a	  chair	  without	  help.	  There	  were	  no	  other	  remarkable	  findings	  on	  
clinical	  examination.	  
Laboratory	  tests	  revealed	  a	  mild	  normocytic	  anaemia	  (Hb	  12.1	  g/dl),	  elevated	  erythrocyte	  sedimentation	  rate	  (ESR)	  of	  
93	  mm/h	  and	  C-­‐reactive	  protein	   (CRP)	  of	  17.4	  mg/dl.	  Rheumatoid	   factor	  and	  anti-­‐citrullinated	  protein	  antibody	  were	  
both	  negative	  as	  well	  as	  the	  antinuclear	  antibodies.	  Tumour	  markers	  were	  also	  negative.	  Hand	  X-­‐rays	  showed	  lesions	  of	  

















Using	   the	  provisional	   classification	   criteria	   for	   PMR	  previously	   published	   [3],	   a	   hypothesis	   of	   PMR	  was	   assumed.	   The	  
patient	  was	  started	  on	  prednisolone	  20	  mg	  daily.	   	  
Figure	  1:	  Hand	  X-­‐ray	  showing	  degenerative	  changes	  in	  both	  hands.	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Three	  weeks	   later,	  only	  slight	  clinical	   improvement	  was	  achieved	  and	  ESR	  remained	  elevated	   (74	  mm/h).	  The	  patient	  
also	   presented	   new	   complaints	   of	   headache	   and	   induration	   of	   the	   temporal	   artery.	   A	   temporal	   artery	   biopsy	   was	  
performed	  and	  prednisolone	  was	  increased	  to	  60	  mg	  daily	  (1	  mg/kg/day)	  pending	  biopsy	  results.	  
In	  4	  weeks,	  the	  inflammatory	  markers	  decreased	  (ESR	  to	  10	  mm/h,	  CRP	  <0.5	  mg/dl),	  anaemia	  improved	  (Hb	  13.4	  g/dl),	  
and	  no	  other	  laboratory	  changes	  were	  identified.	  However,	  clinically	  he	  still	  had	  not	  fully	  recovered,	  reporting	  pain	  and	  
stiffness	  of	  the	  scapular	  and	  pelvic	  girdles.	  
Biopsy	   showed	   no	   histological	   findings	   of	   giant	   cell	   arteritis.	   Prednisolone	   was	   readjusted	   to	   the	   initial	   dose,	   and	   a	  
subsequent	  investigation	  was	  undertaken.	  
The	   CT	   scan	   of	   the	   thorax,	   abdomen	   and	   pelvis	   revealed	   a	   thrombosed	   segment	   of	   the	   splenic	   vein	   (Fig.	   2)	   and	  
abdominal	  MRI	   showed	  a	   tumour	  of	   the	  pancreatic	   tail,	   prolapsing	   to	   and	   compressing	   the	   adjacent	   segment	  of	   the	  
splenic	  vein	  (Fig.	  3).	  
	   	  
Figure	  2:	   Contrast-­‐enhanced	  CT	   scan	   showing	   thrombosed	  segment	  of	   the	  splenic	  
vein	  approximately	  4	  cm	  in	  length.	  
Figure	  3:	  Magnetic	  resonance	  imaging	   (SPAIR	  sequence)	  showing	  tumour	  lesion	  of	  
the	  pancreas.	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The	  patient	  was	  referred	  to	  the	  surgery	  department	  and	  was	  submitted	  to	  a	  distal	  pancreatectomy	  with	  splenectomy.	   	  
Histopathology	   revealed	   a	  well-­‐differentiated	   pancreatic	   neuroendocrine	   neoplasm,	   Ki-­‐67	   of	   10%,	   staged	   as	   pT3	  N0,	  
with	  no	  metastatic	  disease	  identified	  on	  the	  11	  excised	  peripancreatic	  lymph	  nodes.	  
Apart	   from	   secondary	   diabetes	   mellitus,	   the	   overall	   outcome	   was	   favourable.	   There	   was	   no	   recurrence	   of	   clinical	  
symptoms	  of	  pain	  or	  stiffness	  and	  so	  it	  was	  decided	  to	  discontinue	  prednisolone.	  The	  patient	  has	  been	  symptom	  free	  for	  
18	  months	  after	  surgery	  with	  no	  evidence	  of	  relapse	  of	  the	  neoplastic	  disease.	  
	  
Discussion	  
Autoimmune	  diseases	  can	  be	  triggered	  by	  tumour	  development,	  commonly	  referred	  to	  as	  PNS.	  
These	  can	  emerge	  after	  onset	  of	  tumours	  or	  metastases,	  simultaneous	  to	  the	  neoplasm	  diagnosis,	  or	  they	  can	  be	  the	  
cancer’s	  first	  manifestation	  [1].	  
Polymyositis	  and	  dermatomyositis	  are	  the	  most	  commonly	  described	  rheumatic	  disorders	  associated	  with	  PNS	  [1].	  PMR	  
association	  with	  PNS	   is	   still	   controversial,	  but	  a	   few	  reports	  have	  established	  connections	  with	   lung	   [4]	  and	  colon	   [5]	  
adenocarcinoma.	  
Neuroendocrine	   tumours	   (NETs)	   are	   considered	   a	   rare	   type	   of	   neoplasm.	   They	   are	   classiﬁed	   as	   functional	   or	  
non-­‐functional	  according	  to	  the	  presence	  or	  absence,	  respectively,	  of	  clinical	  symptoms	  associated	  with	  the	  production	  
and	  secretion	  of	  various	  neuroendocrine	  mediators.	  Only	  10%	  of	  NETs	  are	  functional	  [2].	  
When	  the	  symptoms	  are	  unusual	  or	  the	  tumour	  is	  non-­‐functional,	  the	  diagnosis	  becomes	  more	  challenging.	  Recognizing	  
the	  existence	  of	  such	  PNS	  is	  important	  as,	  if	  not	  identified,	  it	  may	  delay	  the	  neoplasia	  diagnosis	  [6].	   	  
The	   absence	   of	   a	   sustained	   clinical	   response	   to	   treatment	   led	   us	   to	   expand	   our	   investigation.	   The	   hypothesis	   of	   a	  
concomitant	  giant	  cell	  arteritis	  was	  assumed,	  but	  lack	  of	  complete	  clinical	  response	  to	  corticosteroid	  increment	  together	  
with	  negative	  results	  of	  the	  temporal	  artery	  biopsy	  excluded	  this	  diagnosis,	  directing	  the	  investigational	  study	  towards	  
an	  eventual	  associated	  neoplasia.	   	  
The	  study	  revealed	  a	  pancreatic	  neuroendocrine	  tumour.	  
The	   relationship	   between	   the	   rheumatic	   syndrome	   and	   cancer	  was	   reinforced	   by	   the	   fact	   that	   the	   treatment	   of	   the	  





• It	   is	   critical	   to	   recognize	   the	  presence	  of	   a	  PNS	  as	   it	  may	   lead	   to	   the	  diagnosis	  of	   an	  unsuspected	  underlying	  
neoplasm	  and	  be	  useful	  in	  the	  follow-­‐up	  of	  the	  underlying	  disease.	  
• Whenever	  a	  case	  of	  PMR	  exhibits	  therapeutic	  resistance	  or	  other	  atypical	  features,	  prompt	  investigation	  should	  





Doi:	  10.12890/2014_000146	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   European	  Journal	  of	  Case	  Reports	  in	  Internal	  Medicine	   	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   ©	  EFIM	  2014	  
References	  
	  
1. Fam	  AG.	  Paraneoplastic	  rheumatic	  syndrome,	  Baillieres	  Best	  Pract	  Res	  Clin	  Rheumatol	  2000;14:515–533.	  
2. Milan	  SA,	  Yeo	  CJ.	  Neuroendocrine	  tumors	  of	  the	  pancreas,	  Curr	  Opin	  Oncol	  2012;24:46–55.	  
3. Dasgupta	  B,	  Cimmino	  M,	  Kremers	  H,	  Schmidt	  W,	  Schirmer	  M,	  Salvarani	  C	  et	  al.	  2012	  Provisional	  classification	  
criteria	  for	  polymyalgia	  rheumatica:	  a	  European	  League	  Against	  Rheumatism/American	  College	  of	  Rheumatology	  
collaborative	  initiative,	  Arthritis	  Rheum	  2012;64:943–954.	  
4. Cocquempot	  K,	  Defuentes	  G,	  Duron-­‐Martineau	  S,	  Berets	  O,	  Vaylet	  F,	  Margery	  J.	  Polymyalgia	  rheumatica	  revealing	  
a	  lung	  cancer,	  Rev	  Mal	  Respir	  2013;30:67–70.	  
5. Kehler	  T,	  Curković	  B.	  Polymyalgia	  rheumatica	  and	  colon	  malignancy:	  case	  report.	  Clin	  Rheumatol	  2006;25:764–
765.	   	  
6. Kaltsas	  G,	  Androulakis	  II,	  Herder	  WW,	  Grossman	  AB.	  Paraneoplastic	  syndromes	  secondary	  to	  neuroendocrine	  
tumours,	  Endocr	  Relat	  Cancer	  2010;17:R173–R193.	  
